Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation.
Resda Akhra SyahraniElvira YunitaSeptelias Inawati WanandiPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
YM155 treatment could be used to overcome BCSCs resistance to oxidative stress-based anticancer therapies.